AzTrials
AzTrials

Acute AppendicitisWIRES-TNCT03643718

Web-based International Register of Emergency Surgery and Trauma

An observational study of Acute Appendicitis and Acute Cholecystitis, run by A.O. Ospedale Papa Giovanni XXIII at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The WIRES-T project (Web-based International Registry of Emergency General Surgery and Trauma) has been set up to allow to all the EGS (Emergency General Surgery) and Trauma surgeons to register their activity and to obtain a worldwide register of traumatic and non traumatic surgical emergencies. Read more about this study

Who is it for?
Any age
What is being tested?
Emergency General Surgery
Type of treatment
Surgery or procedure
How many people
10,000 participants
Where
1 siteItaly
Study dates
Jul 2020to Sep 2030
How long will I take part?
2 Weeks
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All patients affected by an acute surgical disease and/or who may require to be undergone to the emergency surgeon attention to be managed either with an operative or a non-operative approach.

Who may be able to join

  • Patients affected by an acute surgical disease
  • Patients with indication to be referred to the emergency surgeon attention
  • Patients to be operated or to be treated with non-operative approach without surgical intervention

Who cannot join

  • Patients not affected by an acute surgical disease
  • Patients without indication to be referred to the emergency surgeon attention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Federico Coccolini, MD contact

0039-050996123

federico.coccolini@gmail.com

Italy1 site, 1 recruiting
  • General, Emergency and Trauma surgery, University Hospital of Pisa

    Pisa

    Federico Coccolini, MD, 050-996123, federico.coccolini@gmail.com

    Recruiting

Other trials in Italy

About this study

The WIRES-T project (Web-based International Registry of Emergency General Surgery and Trauma) has been set up to allow to all the EGS (Emergency General Surgery) and Trauma surgeons to register their activity and to obtain a worldwide register of traumatic and non traumatic surgical emergencies. This will give the opportunity to evaluate results on a macro-data basis and to give index allowing stratifying, evaluating and improving the outcomes.

Being tested
Emergency General Surgery
Medical subject headings
Appendicitis, Cholecystitis, Acute, Pancreatitis, Hernia, Abdominal, Foreign Bodies, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Emergency General SurgeryProcedure or surgery

    Also called Trauma

    Emergency General Surgery and Trauma operative/non operative management

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of patients treated with surgery

    Evaluate the rate of operative treatment for each different disease according to the different enviroment; for each intervention the surgical approach (laparotomic, mini-invasive, laparoscopic) will be evaluated.

    Measured: Until hospital discharge, approximately 2 weeks

  2. Rate of patients treated with conservative treatment

    Evaluate the conservative treatment rate for each different disease according to patient's characteristics and the enviroinment.

    Measured: Until hospital discharge, approximately 2 weeks

Secondary outcomes (2)
  1. Mortality

    To evaluate the differences in mortality rate linked to the different managements, techniques, environments and patient variables.

    Measured: Until hospital discharge, approximately 2 weeks

  2. Morbidity

    To evaluate the differences in morbidity rate linked to the different managements, techniques, environments and patient variables.

    Measured: Until hospital discharge, approximately 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Aug 2018
  2. Study startJul 2020 (estimated)
  3. Primary completionSep 2030 (estimated)
  4. Study completionSep 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10,000 participants (estimated)
Target duration
2 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT03643718
Sponsor's protocol ID
FC-001-2018
Acronym
WIRES-T
Status last verified
Jul 2020
First submitted
14 May 2018
Last updated
14 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Coccolini F, Mazzoni A, Cremonini C, Cobuccio L, Pucciarelli M, Vetere G, Borelli B, Strambi S, Musetti S, Miccoli M, Cremolini C; WIRES-T Study Group; Tartaglia D, Chiarugi M. Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial). Updates Surg. 2023 Sep;75(6):1579-1587. doi: 10.1007/s13304-023-01521-8. Epub 2023 May 9.

    PubMed 37160552

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Appendicitis and Acute Cholecystitis, run by A.O. Ospedale Papa Giovanni XXIII at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Federico Coccolini, MD (0039-050996123, federico.coccolini@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of patients treated with surgery (time frame: Until hospital discharge, approximately 2 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03643718, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2020; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in